VIM and hepatocellular carcinoma: In our study, we demonstrated that knocking down TOP2A inhibited HCC cell migration and invasion in vitro, and inhibited tumor growth and metastasis in vivo, downregulated E-cadherin and upregulated N-cadherin, Vimentin and Slug was observed in HCC cells overexpressing TOP2A.